312 related articles for article (PubMed ID: 23288701)
21. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
[TBL] [Abstract][Full Text] [Related]
22. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.
Williams A; Bartle G; Sumathi VP; Meis JM; Mangham DC; Grimer RJ; Kindblom LG
Virchows Arch; 2011 Mar; 458(3):291-300. PubMed ID: 21279521
[TBL] [Abstract][Full Text] [Related]
23. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
24. [Detection of ASPL-TFE3 fusion gene by reverse transcriptase polymerase chain reaction in paraffin-embedded tumor tissues of alveolar soft part sarcoma].
Pang LJ; Li F; Chang B; Hu WH; Lu TC; Li XX; Li HA; Jiang JF
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):508-12. PubMed ID: 15634444
[TBL] [Abstract][Full Text] [Related]
25. An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms.
Guérin R; Menard AL; Angot E; Piton N; Vera P; Schwarz L; Sabourin JC; Laé M; Thiébaut PA
Diagn Pathol; 2024 Apr; 19(1):62. PubMed ID: 38643139
[TBL] [Abstract][Full Text] [Related]
26. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
[TBL] [Abstract][Full Text] [Related]
27. ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs.
Sicinska E; Kola VSR; Kerfoot JA; Taddei ML; Al-Ibraheemi A; Hsieh YH; Church AJ; Landesman-Bollag E; Landesman Y; Hemming ML
Cancer Res; 2024 Apr; ():. PubMed ID: 38657118
[TBL] [Abstract][Full Text] [Related]
28. ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97.
Pozner A; Verma SP; Li L; Wang S; Barrott JJ; Nelson ML; Yu JSE; Negri GL; Colborne S; Hughes CS; Zhu JF; Lambert SL; Carroll LS; Smith-Fry K; Stewart MG; Kannan S; Jensen B; Mortenson KL; John C; Sikdar S; Liu H; Dang NH; Bourdage J; Li J; Vahrenkamp JM; Groundland JS; Wustrack R; Senger DL; Zemp FJ; Mahoney DJ; Gertz J; Zhang X; Lazar AJ; Hirst M; Morin GB; Nielsen TO; Shen PS; Jones KB
bioRxiv; 2023 Oct; ():. PubMed ID: 37873234
[TBL] [Abstract][Full Text] [Related]
29. High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma.
Selvarajah S; Pyne S; Chen E; Sompallae R; Ligon AH; Nielsen GP; Dranoff G; Stack E; Loda M; Flavin R
Clin Cancer Res; 2014 Mar; 20(6):1521-30. PubMed ID: 24493828
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets.
Covell DG; Wallqvist A; Kenney S; Vistica DT
PLoS One; 2012; 7(11):e48023. PubMed ID: 23226201
[TBL] [Abstract][Full Text] [Related]
31. Primary alveolar soft part sarcoma of the rectum resected by endoscopic submucosal dissection: A case report.
Nakayama A; Yokota A; Suzuki Y; Iizuka T; Fukawa T; Ushiku T; Takazawa Y; Fujii T
Pathol Int; 2020 Aug; 70(8):581-586. PubMed ID: 32515162
[TBL] [Abstract][Full Text] [Related]
32. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
[TBL] [Abstract][Full Text] [Related]
33. ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma.
Jabbour MN; Seoud M; Al-Ahmadie H; Abdul-Karim FW; Zaatari GS
Int J Gynecol Pathol; 2014 May; 33(3):263-7. PubMed ID: 24681737
[TBL] [Abstract][Full Text] [Related]
34. TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas.
Yin X; Wang B; Gan W; Zhuang W; Xiang Z; Han X; Li D
J Exp Clin Cancer Res; 2019 Mar; 38(1):119. PubMed ID: 30849994
[TBL] [Abstract][Full Text] [Related]
35. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
Elife; 2021 Apr; 10():. PubMed ID: 33913810
[TBL] [Abstract][Full Text] [Related]
36. ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21.
Ishiguro N; Yoshida H
Neoplasia; 2016 Oct; 18(10):626-635. PubMed ID: 27673450
[TBL] [Abstract][Full Text] [Related]
37. TFE3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma.
Damayanti NP; Cordova RA; Rupert C; Delle Fontane I; Shen L; Orsi S; Klunk AJ; Linehan WM; Staschke KA; Hollenhorst PC; Heppner DE; Pili R
Cancer Res; 2024 Apr; 84(8):1286-1302. PubMed ID: 38266162
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.
Kauffman EC; Ricketts CJ; Rais-Bahrami S; Yang Y; Merino MJ; Bottaro DP; Srinivasan R; Linehan WM
Nat Rev Urol; 2014 Aug; 11(8):465-75. PubMed ID: 25048860
[TBL] [Abstract][Full Text] [Related]
39. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
[TBL] [Abstract][Full Text] [Related]
40. Gene of the month: TFE 3.
Pinto K; Chetty R
J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
